JP2016517691A5 - - Google Patents

Download PDF

Info

Publication number
JP2016517691A5
JP2016517691A5 JP2016511126A JP2016511126A JP2016517691A5 JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5 JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5
Authority
JP
Japan
Prior art keywords
chinese hamster
sequence
target polypeptide
expression cassette
hamster ovary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016511126A
Other languages
English (en)
Japanese (ja)
Other versions
JP6545153B2 (ja
JP2016517691A (ja
Filing date
Publication date
Priority claimed from GB201308017A external-priority patent/GB201308017D0/en
Priority claimed from GB201320339A external-priority patent/GB201320339D0/en
Application filed filed Critical
Priority claimed from PCT/GB2014/000165 external-priority patent/WO2014177826A1/en
Publication of JP2016517691A publication Critical patent/JP2016517691A/ja
Publication of JP2016517691A5 publication Critical patent/JP2016517691A5/ja
Application granted granted Critical
Publication of JP6545153B2 publication Critical patent/JP6545153B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016511126A 2013-05-03 2014-04-29 発現方法 Active JP6545153B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1308017.1 2013-05-03
GB201308017A GB201308017D0 (en) 2013-05-03 2013-05-03 Expression process
GB1320339.3 2013-11-18
GB201320339A GB201320339D0 (en) 2013-11-18 2013-11-18 Expression Process
PCT/GB2014/000165 WO2014177826A1 (en) 2013-05-03 2014-04-29 Expression process

Publications (3)

Publication Number Publication Date
JP2016517691A JP2016517691A (ja) 2016-06-20
JP2016517691A5 true JP2016517691A5 (https=) 2017-06-08
JP6545153B2 JP6545153B2 (ja) 2019-07-17

Family

ID=50639794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016511126A Active JP6545153B2 (ja) 2013-05-03 2014-04-29 発現方法

Country Status (12)

Country Link
US (3) US9873891B2 (https=)
EP (1) EP2992104B1 (https=)
JP (1) JP6545153B2 (https=)
KR (1) KR102180660B1 (https=)
CN (2) CN114395584B (https=)
BR (1) BR112015027373A2 (https=)
CA (1) CA2910877C (https=)
DK (1) DK2992104T3 (https=)
ES (1) ES2732907T3 (https=)
RU (1) RU2731717C2 (https=)
SG (1) SG11201508447TA (https=)
WO (1) WO2014177826A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3323826A1 (en) * 2016-11-21 2018-05-23 Danmarks Tekniske Universitet Native chinese hamster ovary cell secretion signal peptides for production of recombinant polypeptides
CN111465686B (zh) 2017-12-11 2024-03-22 富士胶片株式会社 动物细胞、动物细胞的制造方法及靶蛋白的制造方法
WO2020122049A1 (ja) 2018-12-11 2020-06-18 富士フイルム株式会社 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法
CN109837277A (zh) * 2019-03-01 2019-06-04 深圳生生凡非基因技术有限公司 一种cpgk嵌合型启动子、腺相关病毒载体及其应用
WO2021107123A1 (ja) 2019-11-29 2021-06-03 富士フイルム株式会社 細胞培養方法、抗体製造方法、有機酸除去方法、及び、抗体
WO2022149607A1 (ja) 2021-01-07 2022-07-14 富士フイルム株式会社 細胞の選択方法、装置、及び装置システム
WO2022196710A1 (ja) 2021-03-17 2022-09-22 富士フイルム株式会社 細胞培養方法、及び有用物質の製造方法
CN112980852B (zh) * 2021-05-18 2021-08-13 北京华芢生物技术有限公司 新型冠状病毒b.1.351南非突变株rbd的基因及其应用
US20230011134A1 (en) 2021-05-27 2023-01-12 Janssen Biotech, Inc. Compositions and methods for the treatment of prostate cancer
EP4410957A4 (en) 2021-09-30 2026-01-28 Fujifilm Corp CELL CULTURE PROCESS AND PROCESS FOR PRODUCING USEFUL SUBSTANCE
EP4450609A1 (en) 2021-12-15 2024-10-23 FUJIFILM Corporation Method for producing product, and cell culture apparatus
CN118974267A (zh) 2022-03-28 2024-11-15 富士胶片株式会社 产物的生产方法及产物
JPWO2023190829A1 (https=) 2022-03-31 2023-10-05
JPWO2023238949A1 (https=) 2022-06-10 2023-12-14
EP4596704A4 (en) 2022-09-29 2026-03-11 Fujifilm Corp PRODUCT PRODUCTION PROCESS
WO2024248118A1 (ja) 2023-05-31 2024-12-05 富士フイルム株式会社 細胞培養方法および生産物の製造方法
CN121175432A (zh) 2023-05-31 2025-12-19 富士胶片株式会社 生产物的生产方法
EP4722377A1 (en) 2023-05-31 2026-04-08 FUJIFILM Corporation Method for producing product
WO2025244971A1 (en) 2024-05-20 2025-11-27 Janssen Biotech, Inc. Compositions and methods for the treatment of prostate cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003223766A1 (en) * 2002-04-30 2003-11-17 University Of North Carolina At Chapel Hill Secretion signal vectors
US7186699B2 (en) * 2003-06-03 2007-03-06 Cell Genesys, Inc. Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
EP1739179A1 (en) * 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
GB0602173D0 (en) * 2006-02-03 2006-03-15 Avecia Ltd Expression system
MX2009007139A (es) * 2006-12-28 2009-10-08 Centocor Ortho Biotech Inc Metodos y vectores para generar inmunoglobulinas no sialiladas.
KR101618767B1 (ko) * 2008-09-02 2016-05-09 한국생명공학연구원 외래단백질을 고효율로 생산하는 리더서열
CA2746350C (en) * 2008-12-31 2018-06-12 Bharat Serums And Vaccines Ltd. Anti-rhd monoclonal antibodies
TWI541021B (zh) 2009-03-05 2016-07-11 艾伯維有限公司 Il-17結合蛋白
GB0905331D0 (en) * 2009-03-27 2009-05-13 Avecia Biolog Ltd Expression process
KR101420274B1 (ko) * 2011-06-13 2014-07-21 주식회사 종근당 Csp-b 5'sar 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법

Similar Documents

Publication Publication Date Title
JP2016517691A5 (https=)
RU2015151626A (ru) Способ экспрессии
PH12020551039A1 (en) Non-viral dna vectors and uses thereof for antibody and fusion protein production
JP2010536396A5 (https=)
HK1207575A1 (en) Bispecific asymmetric heterodimers comprising anti-cd3 constructs
EA202092093A1 (ru) Композиции и способы перепрограммирования tcr с применением слитых белков
JP2016104045A5 (https=)
IL309975B1 (en) Anti-c5 antibodies and uses thereof
HRP20201153T1 (hr) Pd-1 sredstva visokog afiniteta i načini uporabe
JP2015529826A5 (https=)
JP2015525065A5 (https=)
EA202090931A3 (ru) Композиции и способы перепрограммирования tcr с помощью гибридных белков
HRP20191865T1 (hr) Novi heterodimerni proteini
CL2016003096A1 (es) Métodos para cosechar cultivos de células de mamífero
BR112017005245A2 (pt) animal não humano geneticamente modificado, métodos para produzir célula t, hibridoma de célula t, um ácido nucleico, um anticorpo específico, uma célula humana, um animal não humano geneticamente modificado e para induzir uma resposta imunológica, célula, hibridoma de célula t, ácido nucleico, anticorpo específico, receptor de antígeno quimérico, embrião não humano, locus de um receptor de antígeno quimérico, e, composição de ácidos nucleicos.
JP2014110814A5 (https=)
JP2015519055A5 (https=)
HK1243333A1 (zh) 用於修饰的t细胞的方法和组合物
AR063683A1 (es) Anticuerpos para il-17a
RU2014118869A (ru) Мыши с ограниченной тяжелой цепью иммуноглобулина
HRP20201633T1 (hr) Protutijela koja se vežu na il-23
PH12022551580A1 (en) Anti-ctla-4 antibody and use thereof
EP4279136A3 (en) Methods for determining car-t cells dosing
RU2016136855A (ru) Биомаркер-направленная многоцелевая иммунотерапия
JP2013539369A5 (https=)